GlassScriptPhysician profile
Emidio Pantig
NPI 1134174048
$11,755.46
in general payments reported to CMS, 2019-2025
19 companies · $1,490 in 2025
The $1,490 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,281 · 2020: $852 · 2021: $1,265 · 2022: $1,619 · 2023: $1,001 · 2024: $2,248 · 2025: $1,490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,738.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,355.38 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $1,344.41 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $850.40 | 2019-2021 | |
| Lilly USA, LLC | $731.37 | 2019-2025 | Mounjaro, Jardiance |
| Horizon Therapeutics Plc | $666.25 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $652.45 | 2019-2025 | Jardiance |
| Intra-Sana Laboratories | $536.39 | 2023-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Bayer Healthcare Pharmaceuticals INC. | $513.62 | 2022-2025 | |
| Amgen INC. | $476.69 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $288.80 | 2020-2023 | Verquvo |
| Rigel Pharmaceuticals, INC. | $264.24 | 2019 | |
| Avanir Pharmaceuticals, INC. | $249.88 | 2019 | |
| Daiichi Sankyo INC. | $249.36 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $160.93 | 2022-2024 | Trulance, Xifaxan |
| Corcept Therapeutics | $125.00 | 2024 | Korlym |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $125.00 | 2022 | |
| Pfizer INC. | $121.38 | 2021 | |
| Glaxosmithkline, LLC. | $22.90 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $21.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emidio Pantig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.